Chinese ‘Easter Eggs’ fall back to earth after wild year on Wall Street
Shares of Here Group, Zepp Health, Burning Rock Biotech and So-Young International all posted meteoric gains last year, but have given most of that back in 2026 Key Takeaways: A…
Bloks Group’s super-sized profit shows its toys aren’t just child’s play
The toymaker’s 634 million yuan profit for 2025 reversed losses in the previous four years, but its new, ultra-low-priced segment is dragging down margins Key Takeaways: Bloks Group swung to…
Sunny & Sandy joins queue of toymakers aiming to emulate Pop Mart
With revenue growth of 134% in the first nine months of 2025, the company’s Hong Kong IPO could raise over $100 million Key Takeaways: Sunny & Sandy has filed to…
Here Group challenges Labubu with Wakuku
The former adult education company has transformed to a pop toy maker, reporting its revenue from that business rose sharply in its latest quarter Key Takeaways: Here Group’s revenue nearly…
Will Top Toy knock Pop Mart off its throne?
China’s third largest pop toy seller, a spinoff of Japanese-style retailer Miniso, has filed for a Hong Kong IPO just five years after its founding Key Takeaways: Miniso spinoff Top…
QuantaSing excites investors with new toy tune
The adult education company’s shares have tripled since it disclosed a plan to enter the collectible toy business through a major acquisition that closed on March 31 Key Takeaways: QuantaSing…
BRIEF: Miniso hires underwriters for Top Toy IPO
Retailer Miniso Group Holding Ltd. (MNSO.US; 9896.HK) plans to spin off its Top Toy unit for a separate Hong Kong listing, and has hired JPMorgan and UBS to underwrite the…
Recent Articles
RELATED ARTICLES
-
Zeekr drives off Wall Street, heralding chilly year ahead for U.S. Chinese listings
- U.S. tries ‘monkey scaring’ to rid Wall Street of suspicious Chinese listings
- What listings? Small Chinese firms withdraw their Wall Street IPO applications
-
Faded AI beauty: After superstar debut Nuobikan falls back to earth
2635.HK
- Chinese medicine firm seeks elusive elixir of IPO success
-
Tongcheng’s rosy report fails to discuss the worrisome elephant in its house
0780.HK
